Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.

While nanoparticles maximize the amount of chemotherapeutic drug in tumors relative to normal tissues, nanoparticle-based drugs are not accessible to the majority of cancer cells because nanoparticles display patchy, near-perivascular accumulation in tumors. To overcome the limitations of current drugs in their molecular or nanoparticle form, we developed a nanoparticle based on multicomponent nanochains to deliver drug to the majority of cancer cells throughout a tumor while reducing off-target delivery. The nanoparticle is composed of three magnetic nanospheres and one doxorubicin-loaded liposome assembled in a 100 nm long chain. These nanoparticles display prolonged blood circulation and significant intratumoral deposition in tumor models in rodents. Furthermore, the magnetic particles of the chains serve as a mechanical transducer to transfer radio frequency energy to the drug-loaded liposome. The defects on the liposomal walls trigger the release of free drug capable of spreading throughout the entire tumor, which results in a widespread anticancer effect.

[1]  Xin Cai,et al.  A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. , 2011, Journal of the American Chemical Society.

[2]  F. Yuan,et al.  Transvascular drug delivery in solid tumors. , 1998, Seminars in radiation oncology.

[3]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[4]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Sammons Liposomal Anthracyclines for Breast Cancer: Overview , 2003 .

[6]  W. Cowden,et al.  Angiogenesis and Heparanase Activity Assays for in Vitro Tumor Growth and Metastasis Using Novel Identification of Sulfated Oligosaccharide-based Inhibitors of Updated Version , 1999 .

[7]  S. Giri,et al.  Pharmacokinetics, covalent binding and subcellular distribution of [3H]doxorubicin after intravenous administration in the mouse. , 1981, The Journal of pharmacology and experimental therapeutics.

[8]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[9]  L. Chodosh,et al.  Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. , 2011, Neoplasia.

[10]  Y. Barenholz,et al.  Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes. , 1994 .

[11]  Younan Xia,et al.  Gold nanocages covered by smart polymers for controlled release with near-infrared light , 2009, Nature materials.

[12]  Efstathios Karathanasis,et al.  Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. , 2008, Biomaterials.

[13]  P. Rose,et al.  Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. , 2005, The oncologist.

[14]  Y. Sawada,et al.  Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D. , 1984, Journal of pharmacobio-dynamics.

[15]  Paul A Dayton,et al.  Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[16]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[17]  R. Bellamkonda,et al.  Rational identification of a novel peptide for targeting nanocarriers to 9L glioma. , 2008, Journal of biomedical materials research. Part A.

[18]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[19]  L. Lo,et al.  Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release , 2009, Nanotechnology.

[20]  Mi Ae Kim,et al.  Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype , 2005, Oncogene.

[21]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[22]  A. Mazar,et al.  Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. , 1997, Cancer research.

[23]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Efstathios Karathanasis,et al.  Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers , 2009, PloS one.

[25]  D. Tzemach,et al.  Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals , 1997 .

[26]  R. Bellamkonda,et al.  Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. , 2009, Radiology.

[27]  A. Ballangrud,et al.  Binding and interstitial penetration of liposomes within avascular tumor spheroids , 2004, International journal of cancer.

[28]  Michael J Sailor,et al.  Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. , 2009, Small.

[29]  S. Campos Liposomal anthracyclines: adjuvant and neoadjuvant therapy for breast cancer. , 2003, The oncologist.

[30]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[31]  M. Sehested,et al.  Culprit and victim -- DNA topoisomerase II. , 2002, The Lancet. Oncology.

[32]  Heng Huang,et al.  Remote control of ion channels and neurons through magnetic-field heating of nanoparticles. , 2010, Nature nanotechnology.

[33]  John B Weaver,et al.  Concurrent quantification of multiple nanoparticle bound states. , 2011, Medical physics.

[34]  R. Bellamkonda,et al.  Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. , 2009, Biomaterials.

[35]  M. Israel,et al.  Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells. , 1981, Cancer research.

[36]  Daniel Day,et al.  Cancer cell imaging and photothermal therapy using gold nanorods , 2008 .

[37]  Alexander O. Govorov,et al.  Generating heat with metal nanoparticles , 2007 .

[38]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[39]  Liposomal anthracyclines in metastatic breast cancer: clinical update. , 2003, The oncologist.

[40]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[41]  D. Niethammer,et al.  Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). , 1998, International journal of molecular medicine.

[42]  R. B. Campbell,et al.  Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Jinwoo Cheon,et al.  Exchange-coupled magnetic nanoparticles for efficient heat induction. , 2011, Nature nanotechnology.

[44]  I. Tannock,et al.  The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.

[45]  R. Bellamkonda,et al.  Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. , 2011, ACS nano.

[46]  Sérgio Simões,et al.  On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.

[47]  Hairong Zheng,et al.  Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[48]  D. V. Von Hoff,et al.  Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.

[49]  D. Lasič,et al.  Doxorubicin in sterically stabilized liposomes , 1996, Nature.

[50]  Uchiyama,et al.  The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. , 1999, Advanced drug delivery reviews.

[51]  Samir Mitragotri,et al.  Polymer particle shape independently influences binding and internalization by macrophages. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[52]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Peiris,et al.  Assembly of Linear Nano-Chains from Iron Oxide Nanospheres with Asymmetric Surface Chemistry , 2011, PloS one.

[54]  T. Allen,et al.  Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei inMurine Breast , 2005 .

[55]  C. Hunt Liposomes disposition in vivo. V. Liposome stability in plasma and implications for drug carrier function. , 1982, Biochimica et biophysica acta.

[56]  J. Shumaker-Parry,et al.  Asymmetrically functionalized gold nanoparticles organized in one-dimensional chains. , 2008, Nano letters.

[57]  Y. Barenholz,et al.  Gelation of liposome interior A novel method for drug encapsulation , 1992, FEBS letters.

[58]  Yu Zhang,et al.  Gold nanocages covered with thermally-responsive polymers for controlled release by high-intensity focused ultrasound. , 2011, Nanoscale.

[59]  S. Bhatia,et al.  Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging , 2008, Advanced materials.

[60]  Q. Huo,et al.  A "nanonecklace" synthesized from monofunctionalized gold nanoparticles. , 2005, Journal of the American Chemical Society.

[61]  C. Brazel Magnetothermally-responsive Nanomaterials: Combining Magnetic Nanostructures and Thermally-Sensitive Polymers for Triggered Drug Release , 2009, Pharmaceutical Research.